# Qpharm Inc. · 99-39 · CANADA — FDA import alert red lists: firms subject to detention without physical examination

For Qpharm Inc. · 99-39 · CANADA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CANADA; product is Health Supplement Rhoziva; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C; date published is 08/11/2017; address is 3-1000 Bishop St N , Cambridge, Ontario CANADA, verified against its source on 2026-09-16.

- **Firm:** Qpharm Inc. _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** CANADA _(verified: appears in the quote below)_
- **Address:** 3-1000 Bishop St N , Cambridge, Ontario CANADA _(verified: appears in the quote below)_
- **Date published:** 08/11/2017 _(verified: appears in the quote below)_
- **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. _(verified: appears in the quote below)_
- **Product:** Health Supplement Rhoziva _(verified: appears in the quote below)_
- **FDA notes:** Sections 403(e)(1), 403(i)(2), and 403(q)(5)(F) of the Act because the label of each multi- unit container does not meet the exemptions from required label statements. Specifically, the label of each multi-unit container does not bear: 1) the name and place of business of the manufacturer, packer, or distributor, 2) the common or usual name of each ingredient), and 3) nutrition information. The unit container is exempt from these requirements if the unit container bears the statement "This Unit Not Labeled for Retail Sale" [21 CFR 1.24(a)(14)]. Section 403(e)(2) of the Act because the multi-unit label fails to declare the net quantity of contents as required by 21 CFR 101.7. Section 403(s)(2)(B) of the Act because the multi-unit container fails to include a statement of identity as a dietary supplement as required by 21 CFR 101.3(g). Section 403(y) of the Act because the multi-unit container fails to include a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Dietary Supplement and Nonprescription Drug Consumer Protection Act) may receive a report of a serious adverse event with such dietary supplement. _(verified: appears in the quote below)_

## What the source says

> Qpharm Inc. Date Published : 08/11/2017 3-1000 Bishop St N , Cambridge, Ontario CANADA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 08/11/2017 Desc: Health Supplement Rhoziva Notes: Sections 403(e)(1), 403(i)(2), and 403(q)(5)(F) of the Act because the label of each multi- unit container does not meet the exemptions from required label statements. Specifically, the label of each multi-unit container does not bear: 1) the name and place of business of the manufacturer, packer, or distributor, 2) the common or usual name of each ingredient), and 3) nutrition information. The unit container is exempt from these requirements if the unit container bears the statement "This Unit Not Labeled for Retail Sale" [21 CFR 1.24(a)(14)]. Section 403(e)(2) of the Act because the multi-unit label fails to declare the net quantity of contents as required by 21 CFR 101.7. Section 403(s)(2)(B) of the Act because the multi-unit container fails to include a statement of identity as a dietary supplement as required by 21 CFR 101.3(g). Section 403(y) of the Act because the multi-unit container fails to include a domestic address or domestic phone number through which the responsible person (as described in section 761 of the Dietary Supplement and Nonprescription Drug Consumer Protection Act) may receive a report of a serious adverse event with such dietary supplement.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).